| scholarly article | Q13442814 |
| P50 | author | Barton Haynes | Q4865631 |
| Andrew James McMichael | Q21165187 | ||
| Brian Gaschen | Q117221701 | ||
| Elena E Giorgi | Q122828494 | ||
| Bette Korber | Q30505218 | ||
| Cathal Seoighe | Q32937297 | ||
| Beatrice H. Hahn | Q55293537 | ||
| Tanmoy Bhattacharya | Q55414889 | ||
| Guido Ferrari | Q56481169 | ||
| Brandon Keele | Q68690678 | ||
| George M. Shaw | Q78514357 | ||
| P2093 | author name string | Michael Liu | |
| Marcus Daniels | |||
| Natasha Wood | |||
| P2860 | cites work | Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic | Q22010407 |
| The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens | Q22242262 | ||
| Antibody vs. HIV in a clash of evolutionary titans | Q24536059 | ||
| Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection | Q24564623 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood | Q27861000 | ||
| Timing the ancestor of the HIV-1 pandemic strains | Q28137904 | ||
| Quantifying the uncertainty in forecasts of anthropogenic climate change | Q28141336 | ||
| Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models | Q28144403 | ||
| A codon-based model of nucleotide substitution for protein-coding DNA sequences | Q28241397 | ||
| Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin | Q28264707 | ||
| The antigenic structure of the HIV gp120 envelope glycoprotein | Q28274698 | ||
| HyPhy: hypothesis testing using phylogenies | Q29013475 | ||
| Bayes empirical bayes inference of amino acid sites under positive selection | Q29547692 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene | Q29617599 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase | Q29619994 | ||
| Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1. | Q33237376 | ||
| Vaccination and timing influence SIV immune escape viral dynamics in vivo | Q33316821 | ||
| Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage | Q33325923 | ||
| Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions | Q33732677 | ||
| Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost | Q33754974 | ||
| Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. | Q33780595 | ||
| Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels | Q33780649 | ||
| Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution | Q34092644 | ||
| Cellular immune responses to HIV. | Q34223069 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques | Q34301728 | ||
| Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. | Q34353398 | ||
| Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites | Q34569737 | ||
| Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. | Q34617942 | ||
| An HIV vaccine--evolving concepts | Q34629012 | ||
| A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo | Q34858885 | ||
| Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein | Q34981730 | ||
| Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity | Q35101464 | ||
| Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution | Q35634318 | ||
| In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques | Q35748658 | ||
| Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection | Q35857268 | ||
| Mobile genetic elements: the agents of open source evolution | Q36247081 | ||
| Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response | Q36399559 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| Estimating selection pressures on HIV-1 using phylogenetic likelihood models. | Q37081175 | ||
| Models of coding sequence evolution | Q37089708 | ||
| Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope | Q37683431 | ||
| Restraining the conformation of HIV-1 gp120 by removing a flexible loop | Q38774625 | ||
| Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c | Q39028785 | ||
| The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function | Q40417980 | ||
| HIV gp120: double lock strategy foils host defences | Q40843036 | ||
| Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. | Q41672909 | ||
| In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques | Q42248380 | ||
| Widespread adaptive evolution in the human immunodeficiency virus type 1 genome | Q45710774 | ||
| HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry | Q46170039 | ||
| HIV evolution: CTL escape mutation and reversion after transmission | Q47211742 | ||
| Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission | Q47878972 | ||
| Recco: recombination analysis using cost optimization | Q48024454 | ||
| Automated phylogenetic detection of recombination using a genetic algorithm. | Q51938478 | ||
| Reversion of CTL escape–variant immunodeficiency viruses in vivo | Q56427919 | ||
| Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations | Q56880587 | ||
| Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia | Q57075698 | ||
| Potential impact of recombination on sitewise approaches for detecting positive natural selection | Q59192521 | ||
| HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently | Q61053915 | ||
| Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
| Simulation study of the reliability and robustness of the statistical methods for detecting positive selection at single amino acid sites | Q78461368 | ||
| PCR-sequence-specific primer typing of HLA class I and class II alleles | Q78464052 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | e1000414 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC | |
| P478 | volume | 5 |
| Q36472903 | A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans |
| Q21131084 | AID and APOBECs span the gap between innate and adaptive immunity |
| Q47555165 | APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution |
| Q34352429 | APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model |
| Q61449156 | APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome |
| Q34211562 | APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon |
| Q43591116 | APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1. |
| Q38394187 | APOBECs and virus restriction |
| Q34982646 | Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses |
| Q36164165 | Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission |
| Q37952382 | Biological pathways to adaptability--interactions between genome, epigenome, nervous system and environment for adaptive behavior |
| Q38741794 | Calculating site-specific evolutionary rates at the amino-acid or codon level yields similar rate estimates |
| Q59357154 | Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1 |
| Q37856708 | Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems |
| Q35760486 | Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost |
| Q37993616 | DNA sequence variation and regulation of genes involved in pathogenesis of pulmonary tuberculosis |
| Q30410411 | Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications |
| Q35140263 | Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes |
| Q36414547 | Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages |
| Q36000736 | Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape |
| Q54974242 | Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver. |
| Q36157560 | Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein |
| Q39361526 | Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance |
| Q36156679 | Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment |
| Q28481286 | Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n |
| Q42243641 | Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection |
| Q57484166 | Estimating the mutational fitness effects distribution during early HIV infection |
| Q33727328 | Estimating time since infection in early homogeneous HIV-1 samples using a poisson model |
| Q36095984 | Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality |
| Q40047192 | Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes |
| Q51771298 | Evolution and immunity. |
| Q26852372 | Evolution of foamy viruses: the most ancient of all retroviruses |
| Q28710050 | Evolutionary biology for the 21st century |
| Q64237954 | Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses |
| Q36945699 | Future of phylogeny in HIV prevention |
| Q35826158 | Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages |
| Q37273158 | Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection |
| Q34962907 | Genetic imprint of vaccination on simian/human immunodeficiency virus type 1 transmitted viral genomes in rhesus macaques |
| Q35902681 | HIV Restriction Factors and Mechanisms of Evasion |
| Q33822232 | HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model |
| Q39835202 | HIV-1 Protease, Reverse Transcriptase, and Integrase Variation |
| Q35790224 | HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA. |
| Q34473801 | HIV-1 and interferons: who's interfering with whom? |
| Q30397933 | HIV-1 envelope subregion length variation during disease progression |
| Q59811711 | HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth |
| Q40058710 | HIV-1 tolerates changes in A-count in a small segment of the pol gene |
| Q33582135 | High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. |
| Q34115280 | High viral fitness during acute HIV-1 infection |
| Q36303531 | Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment |
| Q36548179 | Host restriction factors in retroviral infection: promises in virus-host interaction |
| Q33982561 | Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection |
| Q34120736 | Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure |
| Q34038460 | Identifying and characterizing recently transmitted viruses |
| Q34593647 | Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies |
| Q35790802 | In-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection. |
| Q35339284 | Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys |
| Q59351278 | Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2'-Deoxyzebularine Analogues |
| Q36220684 | Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes |
| Q33815187 | Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics |
| Q35830651 | Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms |
| Q35993707 | Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response. |
| Q37899341 | Intracellular defenses against HIV, viral evasion and novel therapeutic approaches |
| Q82667285 | Long sequence duplications, repeats, and palindromes in HIV-1 gp120: length variation in V4 as the product of misalignment mechanism |
| Q37257457 | Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS. |
| Q35022585 | Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo |
| Q36585516 | Measuring HIV fusion mediated by envelopes from primary viral isolates |
| Q36019742 | Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation |
| Q36887522 | Modeling sequence evolution in HIV-1 infection with recombination |
| Q34071790 | Molecular evolution of HIV-1 CRF01_AE Env in Thai patients |
| Q33945571 | Molecular tools for studying HIV transmission in sexual networks |
| Q26823568 | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all |
| Q36811895 | Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels |
| Q21144862 | Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity |
| Q24498479 | On the nucleotide composition and structure of retroviral RNA genomes |
| Q93101105 | Parallel evolution of HIV-1 in a long-term experiment |
| Q37206422 | Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions |
| Q92156865 | Phylogenetic measures of indel rate variation among the HIV-1 group M subtypes |
| Q35145382 | Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells |
| Q38879828 | Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections |
| Q34981322 | Potential elucidation of a novel CTL epitope in HIV-1 protease by the protease inhibitor resistance mutation L90M. |
| Q36305433 | Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions |
| Q33602923 | Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation |
| Q37687662 | Quantitative theory of entropic forces acting on constrained nucleotide sequences applied to viruses |
| Q52599337 | Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants. |
| Q27683933 | Random Single Amino Acid Deletion Sampling Unveils Structural Tolerance and the Benefits of Helical Registry Shift on GFP Folding and Structure |
| Q37039116 | Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression |
| Q38849453 | Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection |
| Q36515170 | Recent developments in the effort to cure HIV infection: going beyond N = 1. |
| Q34042642 | Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections |
| Q26827255 | Redefining the viral reservoirs that prevent HIV-1 eradication |
| Q34120265 | Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice |
| Q28534573 | Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine |
| Q34303615 | Retroviral vectors for analysis of viral mutagenesis and recombination |
| Q37207674 | Role of the host restriction factor APOBEC3 on papillomavirus evolution |
| Q36432758 | Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein |
| Q36371387 | Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra. |
| Q34488163 | Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold. |
| Q27684902 | Structural and dynamic changes associated with beneficial engineered single-amino-acid deletion mutations in enhanced green fluorescent protein |
| Q36559921 | Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination |
| Q38887465 | The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence |
| Q24498366 | The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity |
| Q41812539 | The role of cytidine deaminases on innate immune responses against human viral infections. |
| Q33680395 | Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing |
| Q37905885 | Tumour necrosis factor gene polymorphism and disease prevalence |
| Q26861425 | Using nonhuman primates to model HIV transmission |
| Q34270602 | Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection |
| Q39065035 | Viral reverse transcriptases. |
| Q47568875 | Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy |
Search more.